Showing 17,481 - 17,500 results of 45,491 for search '(( 5 ((ng decrease) OR (mean decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 1.36s Refine Results
  1. 17481
  2. 17482

    Maternal Transfer of 2‑Ethylhexyl Diphenyl Phosphate Leads to Developmental Toxicity Possibly by Blocking the Retinoic Acid Receptor and Retinoic X Receptor in Japanese Medaka (Ory... by Yu Li (183836)

    Published 2021
    “…2-Ethylhexyl diphenyl phosphate (EHDPP) has been detected in wild fish with high concentrations, which may pose a risk in the embryo development considering its potential maternal transfer. …”
  3. 17483

    Fiber cell ultrastructure near the bow region up to a depth of 300 μm. by M. Joseph Costello (3043893)

    Published 2016
    “…Note the nucleus is slightly irregular in shape but otherwise normal in appearance with portions of a nucleolus visible. Autophagosomes with double membranes are indicated (yellow arrows), although they decrease in number corresponding to a decrease in membranous organelles in the cytoplasm through this region. …”
  4. 17484

    The efficacy of topical 8% capsaicin patches for the treatment of postsurgical neuropathic pain: a systematic review by Brandon Goodwin (20328988)

    Published 2024
    “…All studies that investigated neuropathic pain area denote a decrease in pain size, with some denoting a continued reduction with subsequent application.…”
  5. 17485
  6. 17486

    Created with BioRender.com. by Simone Schiavo (15999287)

    Published 2024
    “…Thirteen patients had HFpEF (mean LVEF 55 ± 7%), and seven patients had HFrEF (mean LVEF 35 ± 8%) as well as concomitantly decreased right ventricle function (n = 5), moderate/severe tricuspid regurgitation (n = 3), or pulmonary hypertension (n = 5). …”
  7. 17487

    Hyperbaric oxygen therapy details. by Simone Schiavo (15999287)

    Published 2024
    “…Thirteen patients had HFpEF (mean LVEF 55 ± 7%), and seven patients had HFrEF (mean LVEF 35 ± 8%) as well as concomitantly decreased right ventricle function (n = 5), moderate/severe tricuspid regurgitation (n = 3), or pulmonary hypertension (n = 5). …”
  8. 17488

    Supplementary Material for: Peripuberty is a sensitive period for prefrontal parvalbumin interneuron activity to impact adult cognitive flexibility by Sahyoun G.M. (18718144)

    Published 2024
    “…While associative cortical regions like the medial prefrontal cortex (mPFC) do not receive direct sensory input, recent findings demonstrate that changes in activity levels experienced by this region during defined windows in early development may also result in long-lasting changes in prefrontal cortical circuitry, network function and behavior. For example, we recently demonstrated that decreasing the activity of mPFC parvalbumin-expressing (PV) interneurons during a period of time encompassing peripuberty (postnatal day P14) to adolescence (P50) led to a long-lasting decrease in their functional inhibition of pyramidal cells, as well as impairments in cognitive flexibility. …”
  9. 17489

    The Value of Dynamic Grip Force Modulation as a Potential Biomarkerfor Hand Function Recovery Following Stroke by Kirstin-Friederike Heise (7518953)

    Published 2024
    “…We extracted separate outcome parameters from the grip force profiles describing distinct components such as a) speed of force increase and b) decrease, as well as c) median precision and d) variability of constant force production.…”
  10. 17490
  11. 17491

    UBKIs possess broad antiviral activity, are effective in primary cells, and impose a barrier against resistance development. by Markus Lesch (6475409)

    Published 2019
    “…The experiment was terminated after 8 passages. Data represent mean ± SD of technical replicates.</p>…”
  12. 17492

    Data_Sheet_1_Brain cortical alterations in COVID-19 patients with neurological symptoms.docx by Gretel Sanabria-Diaz (436165)

    Published 2022
    “…II–III), with age, sex, MRI magnetic field strength, and total intracranial volume/mean thickness/total surface area as covariates. …”
  13. 17493

    Triple immunofluorescence labeling comparing both sarcomeric actin and VDAC expression in control versus MFN2 mutant mice. by Peter Bannerman (3373028)

    Published 2016
    “…Initially, note the selective expression of the mutant form of MFN2 in satellite cells of the mutant myofibers with occasion dissemination into the muscle fiber (white arrow-heads). Also note both the decreased intensity of sarcomeric actin immunolabelling in the mutant mice versus wild-type mice (compare A and B) and the relative disruption of striated myofibrillar distribution of VDAC positive mitochondria in mutant micrograph D versus C. …”
  14. 17494

    Drug-Eluting versus Bare-Metal Stent for Treatment of Saphenous Vein Grafts: A Meta-Analysis by Pascal Meier (207362)

    Published 2010
    “…The mortality was not significantly different between DES and BMS in the RCT's (OR 2.22 [0.17 – 29.50]; p = 0.546) while the observation studies showed a decreased mortality in the DES group (0.69 [0.55–0.85]; p<0.001).…”
  15. 17495

    Effect of ACE inhibitors on the binding of a set of anti-ACE mAbs to blood ACE. by Maxim N. Petrov (118931)

    Published 2012
    “…Serum pooled from 30 healthy donors and diluted 1/5 in PBS (50 µl) was incubated with or without ACE inhibitors for 1 hour at 37oC and then was incubated overnight with microtiter plate coated with different anti-ACE mAbs (3 µg/ml) via goat-anti-mouse bridge. …”
  16. 17496

    In-Car Nocturnal Blue Light Exposure Improves Motorway Driving: A Randomized Controlled Trial by Jacques Taillard (125714)

    Published 2012
    “…<div><p>Prolonged wakefulness greatly decreases nocturnal driving performance. The development of in-car countermeasures is a future challenge to prevent sleep-related accidents. …”
  17. 17497
  18. 17498
  19. 17499

    The APPLe Study: A Randomized, Community-Based, Placebo-Controlled Trial of Azithromycin for the Prevention of Preterm Birth, with Meta-Analysis by Nynke R. van den Broek (248401)

    Published 2009
    “…There were no significant differences in outcome between the azithromycin group (<em>n</em> = 1,096) and the placebo group (<em>n</em> = 1,087) in respect of preterm birth (16.8% versus 17.4%), odds ratio (OR) 0.96, 95% confidence interval (0.76–1.21); mean gestational age at delivery (38.5 versus 38.4 weeks), mean difference 0.16 (−0.08 to 0.40); mean birthweight (3.03 versus 2.99 kg), mean difference 0.04 (−0.005 to 0.08); perinatal deaths (4.3% versus 5.0%), OR 0.85 (0.53–1.38); or maternal malarial parasitaemia (11.5% versus 10.1%), OR 1.11 (0.84–1.49) and anaemia (44.1% versus 41.3%) at 28–32 weeks, OR 1.07 (0.88–1.30). …”
  20. 17500

    Inhibition of growth and proliferation of MCF7 cells. by Fazal Khan (3149331)

    Published 2016
    “…These decreases in inhibitions were statistically significant. …”